Filing Details
- Accession Number:
- 0001437749-21-027339
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-23 20:02:07
- Reporting Period:
- 2021-11-19
- Accepted Time:
- 2021-11-23 20:02:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739054 | Kim Kelderman | 614 Mckinley Place Ne Minneapolis MN 55413 | Pres. Diagnostics & Genom | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-19 | 500 | $150.78 | 500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-19 | 100 | $503.76 | 400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-19 | 400 | $505.78 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-11-19 | 500 | $0.00 | 500 | $150.78 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,152 | 2025-05-01 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $150.78 | 2025-05-01 | 7,348 | 7,348 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $177.32 | 2025-08-08 | 12,044 | 12,044 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $177.32 | 2025-08-08 | 9,033 | 9,033 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 2,363 | 2,363 | Direct | ||
| Common Stock | Stock Option (Right to Buy) | $190.41 | 2026-08-07 | 11,961 | 11,961 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $190.41 | 2026-08-07 | 15,948 | 15,948 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 2,015 | 2,015 | Direct | ||
| Common Stock | Stock Option (Right to Buy) | $267.87 | 2027-08-05 | 8,991 | 8,991 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $267.87 | 2027-08-05 | 11,988 | 11,988 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $267.87 | 2027-08-05 | 8,325 | 8,325 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $267.87 | 2027-08-05 | 8,325 | 8,325 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 1,245 | 1,245 | Direct | ||
| Common Stock | Stock Option (Right to Buy) | $481.82 | 2028-08-06 | 4,864 | 4,864 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $481.82 | 2028-08-06 | 6,486 | 6,486 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2025-05-01 | 7,348 | 7,348 | Direct |
| 2025-08-08 | 12,044 | 12,044 | Direct |
| 2025-08-08 | 9,033 | 9,033 | Direct |
| 2,363 | 2,363 | Direct | |
| 2026-08-07 | 11,961 | 11,961 | Direct |
| 2026-08-07 | 15,948 | 15,948 | Direct |
| 2,015 | 2,015 | Direct | |
| 2027-08-05 | 8,991 | 8,991 | Direct |
| 2027-08-05 | 11,988 | 11,988 | Direct |
| 2027-08-05 | 8,325 | 8,325 | Direct |
| 2027-08-05 | 8,325 | 8,325 | Direct |
| 1,245 | 1,245 | Direct | |
| 2028-08-06 | 4,864 | 4,864 | Direct |
| 2028-08-06 | 6,486 | 6,486 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $505.62 to $506.17, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
- Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
- Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
- Fully exercisable.
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
- Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
- Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
- Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
- Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.
Billionaire Hedge Funds
